循环表观遗传特征用于分类人类脑胰岛素抵抗
研究基于无2型糖尿病参与者的血液DNA甲基化谱,用机器学习框架识别脑胰岛素抵抗分类器。在发现队列(n=167)中筛选出540个甲基化位点(CpGs),并在两个复制队列(n=33和24)中以83%至94%的高准确率验证。540个CpGs均差异甲基化并注释到445个基因,其中98个CpGs的甲基化模式与脑组织显著相关。
要点
- 基于血液DNA甲基化的机器学习框架可分类脑胰岛素抵抗。
- 540个CpGs在发现队列识别,两个复制队列验证准确率83%至94%。
- 98/540个CpGs显示血液-脑甲基化显著相关(P<0.05)。
核心结论
- 血液表观遗传特征未来可能用于广泛临床环境中脑胰岛素抵抗个体的早期检测。
研究设计与样本
- 基于无2型糖尿病参与者的血液DNA甲基化谱和详细代谢表型,开发机器学习框架。
- 发现队列n=167,两个复制队列n=33和n=24。
主要发现
- 发现队列中识别540个DNA甲基化位点(CpGs)作为脑胰岛素抵抗分类器。
- 两个复制队列验证准确率83%至94%。
- 540个CpGs均差异甲基化,注释到445个基因,映射到神经元发育和轴突发生过程。
- 540个CpGs中98个的甲基化模式显示强且显著的血液-脑相关(P<0.05)。
关键数值与推荐
- 540个CpGs中98个显示血液-脑甲基化相关P<0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brain insulin action plays an important role in metabolic and cognitive health, but there is no biomarker available to assess brain insulin resistance in humans. Here, we developed a machine learning framework based on blood DNA methylation profiles of participants who did not have type 2 diabetes with and without brain insulin resistance and detailed metabolic phenotyping. We identified 540 DNA methylation sites (CpGs) as classifiers of brain insulin resistance in a discovery cohort (n = 167), results that were validated in two replication cohorts (n = 33 and 24) with high accuracy (83 to 94%). All 540 CpGs were differentially methylated and annotated to 445 genes mapping to neuronal development and axonogenesis processes. Methylation patterns of 98 of 540 CpGs exhibited a strong and significant (P < 0.05) blood-brain correlation, indicating that blood cells are a reliable proxy to capture brain-specific DNA methylation changes. These blood-based epigenetic signatures could potentially serve in the future for the early detection of individuals with brain insulin resistance in a broad clinical setting.
引用
- Kullmann S, Singh A, Sehgal R, et al. Circulating epigenetic signatures classifying brain insulin resistance in humans. Sci Transl Med. 2025. PMID: 40768600. doi:10.1126/scitranslmed.adv7834
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。